Drug Approvals in 2023 Deepu Asok 10 Mar 2023 Photo by Myriam Zilles / Unsplash Table of Contents JanuaryAstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma TreatmentMarchPfizer's Zavegepant Nasal Spray for Migraine is now approvedFDA approves first Rett's Syndrome Drug Share on Twitter Share on Facebook Share on LinkedIn Share on Pinterest Share via Email Copy link Deepu Asok Twitter Deepu Asok Newsletter Join the newsletter to receive the latest updates in your inbox. Your email address Subscribe Please check your inbox and click the link to confirm your subscription. Please enter a valid email address! An error occurred, please try again later.